Amwise Diagnostic Company

Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
Technology: diagnostics
Industry: Biotechnology, Health Care, Life Science
Headquarters: Taiwan
Founded Date: 42005
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: $10M
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-02-26
Last Funding Type: Series B

Visit Website
Register and Claim Ownership